Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5182 | 1591 | 39.3 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
165 | 21626 | PARKINSONS DISEASE//DEEP BRAIN STIMULATION//MOVEMENT DISORDERS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DOPAMINE TRANSPORTER | Author keyword | 48 | 16% | 17% | 269 |
2 | DOPAMINE TRANSPORTER IMAGING | Author keyword | 26 | 68% | 1% | 23 |
3 | I 123 FP CIT | Author keyword | 26 | 64% | 2% | 25 |
4 | FLUORODOPA | Author keyword | 24 | 63% | 2% | 24 |
5 | IODINE 123 BETA CIT | Author keyword | 17 | 100% | 1% | 8 |
6 | FDOPA | Author keyword | 16 | 51% | 1% | 22 |
7 | PE2I | Author keyword | 15 | 82% | 1% | 9 |
8 | I 123FP CIT | Author keyword | 14 | 65% | 1% | 13 |
9 | DATSCAN | Author keyword | 13 | 49% | 1% | 20 |
10 | 6 F 18FLUORO L DOPA | Author keyword | 13 | 61% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOPAMINE TRANSPORTER | 48 | 16% | 17% | 269 | Search DOPAMINE+TRANSPORTER | Search DOPAMINE+TRANSPORTER |
2 | DOPAMINE TRANSPORTER IMAGING | 26 | 68% | 1% | 23 | Search DOPAMINE+TRANSPORTER+IMAGING | Search DOPAMINE+TRANSPORTER+IMAGING |
3 | I 123 FP CIT | 26 | 64% | 2% | 25 | Search I+123+FP+CIT | Search I+123+FP+CIT |
4 | FLUORODOPA | 24 | 63% | 2% | 24 | Search FLUORODOPA | Search FLUORODOPA |
5 | IODINE 123 BETA CIT | 17 | 100% | 1% | 8 | Search IODINE+123+BETA+CIT | Search IODINE+123+BETA+CIT |
6 | FDOPA | 16 | 51% | 1% | 22 | Search FDOPA | Search FDOPA |
7 | PE2I | 15 | 82% | 1% | 9 | Search PE2I | Search PE2I |
8 | I 123FP CIT | 14 | 65% | 1% | 13 | Search I+123FP+CIT | Search I+123FP+CIT |
9 | DATSCAN | 13 | 49% | 1% | 20 | Search DATSCAN | Search DATSCAN |
10 | 6 F 18FLUORO L DOPA | 13 | 61% | 1% | 14 | Search 6+F+18FLUORO+L+DOPA | Search 6+F+18FLUORO+L+DOPA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 6 F 18FLUORO L DOPA | 84 | 71% | 4% | 68 |
2 | I 123 BETA CIT | 70 | 46% | 7% | 113 |
3 | MONOAMINE REUPTAKE SITES | 57 | 78% | 2% | 38 |
4 | FLUORODOPA | 48 | 76% | 2% | 34 |
5 | I 123 IOFLUPANE | 42 | 94% | 1% | 15 |
6 | STRIATAL UPTAKE | 39 | 73% | 2% | 30 |
7 | DOPAMINE TRANSPORTER SPECT | 35 | 86% | 1% | 18 |
8 | IODINE 123 BETA CIT | 33 | 74% | 2% | 25 |
9 | BETA CIT | 33 | 45% | 3% | 55 |
10 | F 18 FLUORODOPA | 30 | 84% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice | 2015 | 2 | 103 | 51% |
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (I-123) ioflupane in diagnosis of parkinsonian syndromes | 2013 | 24 | 40 | 48% |
The role of radiotracer imaging in Parkinson disease | 2005 | 180 | 53 | 53% |
Role of DAT-SPECT in the diagnostic work up of Parkinsonism | 2007 | 83 | 93 | 47% |
SPECT imaging evaluation in movement disorders: far beyond visual assessment | 2011 | 21 | 53 | 72% |
Effects of Levodopa on Regional Cerebral Metabolism and Blood Flow | 2015 | 1 | 59 | 31% |
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration | 2011 | 40 | 151 | 42% |
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach | 2009 | 60 | 54 | 44% |
The role of DAT-SPECT in movement disorders | 2010 | 70 | 70 | 34% |
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches | 2009 | 32 | 78 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HLTH SCI B2 086A | 8 | 100% | 0.3% | 5 |
2 | PACIFIC PARKINSONS | 6 | 18% | 1.9% | 30 |
3 | MT GODINNE MED | 4 | 47% | 0.4% | 7 |
4 | ETUD METAB MOL MARQUEES | 4 | 75% | 0.2% | 3 |
5 | ZATE | 4 | 75% | 0.2% | 3 |
6 | BIOPHYS MED PHARMACEUT | 3 | 20% | 0.8% | 13 |
7 | NUCL MED EUROMED SZEGED | 3 | 50% | 0.3% | 4 |
8 | SMALL ANIM IMAGING UNIT | 3 | 42% | 0.3% | 5 |
9 | MINIST HLTH PRC | 2 | 44% | 0.3% | 4 |
10 | UBC TRIUMF PET PROGRAM | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000207179 | SEROTONIN TRANSPORTER//4 F 18 ADAM//I 123 ADAM |
2 | 0.0000191744 | TRANSCRANIAL SONOGRAPHY//SUBSTANTIA NIGRA HYPERECHOGENICITY//BRAIN PARENCHYMA SONOGRAPHY |
3 | 0.0000190255 | C 11RACLOPRIDE//C 11FLB 457//F 18 FALLYPRIDE |
4 | 0.0000123225 | MULTIPLE SYSTEM ATROPHY//STRIATONIGRAL DEGENERATION//OLIVOPONTOCEREBELLAR ATROPHY |
5 | 0.0000116974 | PSYCHOBIOL SECT//BENZTROPINE ANALOGS//GBR 12909 |
6 | 0.0000114296 | PARKINSONS DISEASE DEMENTIA//MOTOR SUBTYPE//SECT PARKINSON DIS MOVEMENT DISORDERS |
7 | 0.0000097518 | TETRABENAZINE//VMAT2//VESICULAR MONOAMINE TRANSPORTER |
8 | 0.0000091620 | FLUORINE 18//F 18SFB//RADIOFLUORINATION |
9 | 0.0000080775 | DOTARIZINE//DRUG INDUCED PARKINSONISM//CINNARIZINE |
10 | 0.0000073790 | DEMENTIA WITH LEWY BODIES//LEWY BODY DISEASE//DIFFUSE LEWY BODY DISEASE |